Table 3. Biomarkers and therapeutic targets for Androgen Sensitivity.
| Average Fold Change Across All Samples | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Target Molecule | Accession Number | LNCaP 8h Control | LNCaP 8h DMOG | LNCaP 24h Control | LNCaP 24 DMOG | Abl 8h Control | Abl 8h DMOG | Abl 24h Control | Abl 24h DMOG | Hof 8h Control | Hof 8h DMOG | Hof 24h Control | Hof 24h DMOG | Number of Drugs |
| TOP2A | P11388 | +0.979 | +1.548 | -0.313 | -0.766 | -0.360 | -0.393 | 20+ | ||||||
| PARP1 | P09874 | +1.050 | +1.793 | +1.043 | +0.884 | -0.691 | -0.701 | -0.878 | -0.967 | -0.482 | -0.498 | -0.787 | -0.322 | 8 |
| CAT | P04040 | -1.102 | -1.491 | -1.633 | -1.200 | +0.113 | +0.214 | +0.541 | +0.486 | +0.957 | +0.919 | +0.778 | +1.012 | 1 |
| TXN | P10599 | +1.007 | +0.830 | +0.849 | +1.133 | -0.513 | -0.912 | -1.138 | -0.572 | -0.658 | -0.773 | -0.688 | -0.599 | 1 |
| ABCC1 | P33527 | +1.345 | +1.154 | -0.754 | -0.335 | -0.598 | -0.318 | 1 | ||||||